Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells, covering 2016-10-06 to 2016-10-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction [Phase 3]